Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:11 pm Purchase |
2024-09-30 | 13G | AbCellera Biologics Inc. ABCL |
Baker Bros. Advisors LP | 27,525,640 9.300% |
4,615,887 (+20.15%) |
Filing History |
| 2024-10-10 5:01 pm Purchase |
2024-10-08 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,507,193 65.600% |
2,507,193 (New Position) |
Filing History |
| 2024-10-08 5:29 pm Purchase |
2024-10-04 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA |
Baker Bros. Advisors LP | 3,151,029 7.700% |
3,151,029 (New Position) |
Filing History |
| 2024-08-22 4:15 pm Purchase |
2024-08-21 | 13D | Kymera Therapeutics, Inc. KYMR |
Baker Bros. Advisors LP | 6,001,262 9.300% |
3,556 (+0.06%) |
Filing History |
| 2024-06-28 4:11 pm Purchase |
2024-06-26 | 13D | Kala Pharmaceuticals, Inc. KALA |
Baker Bros. Advisors LP | 891,335 19.990% |
622,122 (+231.09%) |
Filing History |
| 2024-06-26 4:54 pm Purchase |
2024-06-24 | 13D | Entrada Therapeutics, Inc. TRDA |
Baker Bros. Advisors LP | 4,865,819 13.200% |
161,400 (+3.43%) |
Filing History |
| 2024-06-14 6:52 pm Purchase |
2024-06-14 | 13D | HOOKIPA Pharma Inc. HOOK |
Baker Bros. Advisors LP | 981,315 9.990% |
166,417 (+20.42%) |
Filing History |
| 2024-06-14 6:23 pm Sale |
2024-06-12 | 13D | Incyte Corporation INCY |
Baker Bros. Advisors LP | 31,209,896 16.300% |
-5,459,183 (-14.89%) |
Filing History |
| 2024-05-28 4:16 pm Purchase |
2024-05-23 | 13D | Bicycle Therapeutics plc BCYC |
Baker Bros. Advisors LP | 9,399,960 19.900% |
1,710,717 (+22.25%) |
Filing History |
| 2024-05-13 6:06 pm Unchanged |
2024-05-12 | 13D | Incyte Corporation INCY |
Baker Bros. Advisors LP | 36,669,079 16.300% |
0 (Unchanged) |
Filing History |
| 2024-05-09 6:40 pm Purchase |
2024-05-07 | 13D | Incyte Corporation INCY |
Baker Bros. Advisors LP | 36,669,079 16.300% |
27,617 (+0.08%) |
Filing History |
| 2024-04-23 4:25 pm Purchase |
2024-04-19 | 13D | TScan Therapeutics, Inc. TCRX |
Baker Bros. Advisors LP | 2,828,938 6.100% |
35,000 (+1.25%) |
Filing History |
| 2024-04-18 07:29 am Purchase |
2024-04-16 | 13D | Bicycle Therapeutics plc BCYC |
Baker Bros. Advisors LP | 7,689,243 19.900% |
2,865,645 (+59.41%) |
Filing History |
| 2024-04-01 08:57 am Purchase |
2024-03-28 | 13D | Kymera Therapeutics, Inc. KYMR |
Baker Bros. Advisors LP | 5,997,706 9.800% |
1,778 (+0.03%) |
Filing History |
| 2024-03-28 7:13 pm Purchase |
2024-03-28 | 13D | IGM Biosciences, Inc. IGMS |
Baker Bros. Advisors LP | 4,145,706 12.400% |
401,037 (+10.71%) |
Filing History |
| 2024-03-25 4:28 pm Purchase |
2024-03-21 | 13D | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 2,070,544 9.990% |
82,842 (+4.17%) |
Filing History |
| 2024-03-05 4:24 pm Purchase |
2024-02-27 | 13D | vTv Therapeutics Inc. VTVT |
Baker Bros. Advisors LP | 122,664 4.990% |
122,664 (New Position) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | 2seventy bio, Inc. TSVT |
Baker Bros. Advisors LP | 2,527,672 4.990% |
464,928 (+22.54%) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Baker Bros. Advisors LP | 22,909,753 7.900% |
22,909,753 (New Position) |
Filing History |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Achilles Therapeutics plc ACHL |
Baker Bros. Advisors LP | 3,311,567 8.100% |
-896,166 (-21.30%) |
Filing History |